Clebopride malate NEW
| Price | $30 | $40 | $64 |
| Package | 5mg | 10mg | 25mg |
| Min. Order: | |
| Supply Ability: | 10g |
| Update Time: | 2025-12-05 |
Product Details
| Product Name: Clebopride malate | CAS No.: 57645-91-7 |
| Purity: 99.52% | Supply Ability: 10g |
| Release date: 2025/12/05 |
Product Introduction
Bioactivity
| Name | Clebopride malate |
| Description | Clebopride malate is a dopamine antagonist used to treat functional gastrointestinal disorders, such as nausea or vomiting. |
| In vivo | Clebopride, a new benzamide derivative, has, in common with the other members of this group,and with antiemetic drug, antidopaminergic activity.?In animals, its therapeutic ratio is superior to that of metoclopramide at doses free of side effects associated with hyperprolactinemia and extrapyramidal symptoms[1]. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 34 mg/mL (66.93 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2.5 mg/mL (4.92 mM), Sonication is recommended. |
| Keywords | Inhibitor | inhibit | DopamineReceptor | Dopamine Receptor | Dopamine | Clebopride malate | Clebopride Malate | Clebopride |
| Inhibitors Related | Trifluoperazine dihydrochloride | Clozapine N-Oxide | Octopamine hydrochloride | L-DOPA | Dexmedetomidine hydrochloride | Isoprenaline hydrochloride | Citicoline | Creatine | D-Mannitol | Oxolinic acid | Trazodone hydrochloride | Mianserin hydrochloride |
| Related Compound Libraries | FDA-Approved & Pharmacopeia Drug Library | Bioactive Compound Library | Anti-Neurodegenerative Disease Compound Library | Approved Drug Library | Membrane Protein-targeted Compound Library | Neurotransmitter Receptor Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $0.00/25kg |
VIP6Y
|
Sichuan Zhuoyu Yantang Technology Co., Ltd.
|
2025-09-16 | |
| $1980.00/50mg |
VIP2Y
|
TargetMol Chemicals Inc.
|
2025-08-21 | |
| $10.00/1ASSAYS |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-08-19 | |
| $300.00/1kg |
Hebei Mingeng Biotechnology Co., Ltd
|
2022-05-05 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY